Skip to main content

Point72 Asset Management, L.P.

Position in AVTX — Avalo Therapeutics, Inc.

CIK 1603466 STAMFORD, CT

Position in AVTX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$44,112,240
+$30,434,240 QoQ
Shares Held
2,387,026
+160.6% QoQ
Ownership
4.45%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#9
of 126 holders
Holding Since
Mar 2021
13 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in AVTX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Point72 Asset Management, L.P. holds $2,243,273,342 across 172 Biotechnology names. AVTX ranks #15 (2.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in AVTX

Export CSV
15 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $44,112,240 2,387,026
2026-05-22 $44,348,966 2,710,817
2026-03-31 $13,678,000 916,142
2025-12-31 $11,395,436 627,502
2025-09-30 $13,396,123 1,053,983
2025-08-04 $5,280,029 588,632
2023-03-31 $1,926,289 1,100,737
2022-12-31 $2,523,714 500,737
2022-09-30 $1,662,446 500,737
2022-06-30 $3,004,424 6,008,850
2022-03-31 $4,356,416 6,008,850
2021-12-31 $10,215,044 6,008,850
2021-09-30 $13,099,292 6,008,850
2021-06-30 CERC 1,304,533
2021-03-31 CERC 2,450,000